STARTUP PROFILE

Linus Health

COUNTRY
USA
FOUNDED
2019
CATEGORY
Diagnostics and Assessment
Developing digital cognitive assessment and decision-support tools to enable earlier detection and management of neurodegenerative disease.
Visit website →
Neurofounders Insights
$   Funding   -
Series B
MODALITY
Software
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Dementia/impairment
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
Linus Health is one of the more commercially advanced digital cognitive assessment platforms, combining validated tests, decision support, and acquired biomarker capabilities such as speech analytics. Its positioning is strongest as a clinician-facing dementia workflow platform rather than a breakthrough biomarker company.
Mentioned in Market Notes
MOST RECENT COVERAGE
#
3
The Big June Data Dump
9 June – 23 June 2026

A missed entry from last Market Notes: on the 26th of May, Linus Health reported that its digital cognitive assessments met or exceeded the criteria set out in recent recommendations for clinic-based digital cognitive assessments. Against the CEOi detection benchmarks, its remote-enabled Digital Assessment of Cognition reported 90.7% sensitivity and 100% specificity in an independent test set. The data support the use of brief, scalable digital tools as alternatives to legacy paper-based screening in primary care.

Articles featuring
Linus Health
No items found.